Sign Out
Rabeprazole sodium (Reloxa) tablets are indicated for the treatment of: Active duodenal ulcer.
Active benign gastric ulcer.
Symptomatic erosive or ulcerative gastroesophageal reflux disease (GERD).
H. pylori-positive duodenal ulcers, as part of the eradication programme with appropriate antibiotics.
Maintenance treatment of healed erosive or ulcerative GERD.
Efficacy has not been demonstrated for periods exceeding 12 months.
